Analysts expect Upstream Bio, Inc. to report revenue of 511,835.78 for Q3 26, against a range of 477,538.18 to 546,133.38. The most recent reported quarter, Q2 26, came in at 773,000.00, a 75.5% beat against the 440,439.69 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 607,000.00 | 613,000.00 | 566,000.00 | 937,000.00 | 683,000.00 | 668,000.00 | 1.03 M | 773,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 451,878.46 | 375,574.22 | 378,086.02 | 312,760.18 | 693,730.21 | 678,747.53 | 610,341.24 | 463,842.45 | 546,133.38 | 573,781.10 | 456,867.36 | 405,871.16 | 347,976.43 | 388,552.23 | 1.04 M | 1.28 M | ||||||||||
| Low Estimate | 406,365.76 | 346,642.92 | 311,110.58 | 282,930.38 | 638,748.15 | 594,230.69 | 554,886.86 | 417,036.93 | 477,538.18 | 521,472.86 | 397,114.26 | 373,389.24 | 298,535.71 | 363,852.29 | 859,827.92 | 1.15 M | ||||||||||
| Consensus Estimate | 429,122.11 | 361,108.57 | 344,598.30 | 297,845.28 | 666,239.18 | 636,489.11 | 582,614.05 | 440,439.69 | 511,835.78 | 547,626.98 | 426,990.81 | 389,630.20 | 323,256.07 | 376,202.26 | 949,544.70 | 1.22 M |
Analysts expect Upstream Bio, Inc. to report earnings per share of -0.77 for Q3 26, against a range of -0.81 to -0.73. The most recent reported quarter, Q2 26, came in at -0.73, a 4.3% miss against the -0.70 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -6.96 | -0.41 | -0.51 | -0.74 | -0.63 | -0.78 | -0.75 | -0.73 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -6.99 | -0.53 | -0.44 | -0.58 | -0.70 | -0.70 | -0.65 | -0.65 | -0.73 | -0.63 | -0.74 | -0.75 | -0.05 | 0.36 | -1.16 | -1.49 | ||||||||||
| Low Estimate | -7.43 | -0.61 | -0.50 | -0.68 | -0.78 | -0.80 | -0.73 | -0.75 | -0.81 | -0.75 | -0.84 | -0.81 | -0.05 | 0.34 | -1.36 | -1.63 | ||||||||||
| Consensus Estimate | -7.21 | -0.57 | -0.47 | -0.63 | -0.74 | -0.75 | -0.69 | -0.70 | -0.77 | -0.69 | -0.79 | -0.78 | -0.05 | 0.35 | -1.26 | -1.56 |
Pull Wall Street consensus for Upstream Bio, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=UPB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "UPB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=UPB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();